David Shields is an accomplished professional in R&D Innovation within the TechBio sector. They completed a Doctor of Philosophy in Biochemistry at the University of Alberta and gained extensive experience as a Postdoctoral Fellow at both the University of Alberta and The Scripps Research Institute. David has held various strategic roles at Pfizer, including Vice President and Head of the Pfizer Centers for Therapeutic Innovation, where they led collaborative drug discovery efforts across multiple therapeutic areas. Currently, David serves as the Global Head of Asset Projects at Recursion, continuing their leadership in advancing innovative scientific research.
This person is not in the org chart
This person is not in any teams
This person is not in any offices